These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27461631)

  • 1. Meta-analysis of the relationship between microRNA-499 rs3746444 polymorphism and hepatocellular carcinoma risk in Asians.
    Wang W; Qin H; Zhou L; Ma J
    J Cancer Res Ther; 2016; 12(2):676-80. PubMed ID: 27461631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-499 rs3746444 polymorphism and hepatocellular carcinoma risk: A meta-analysis.
    Qiu D; Han F; Zhuang H
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S490-S493. PubMed ID: 29970712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A meta-analysis of microRNA-149, microRNA-499 gene polymorphism and susceptibility to hepatocellular carcinoma].
    Ye LX; Fu CW; Jiang F; Cui YX; Meng W
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 May; 50(5):445-50. PubMed ID: 27141902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between miR-499 rs3746444 and the susceptibility of hepatocellular carcinoma.
    Yu H; Wang Y; Wang S; Sun N
    Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):42-5. PubMed ID: 27453271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association study of two inflammation-related polymorphisms with susceptibility to hepatocellular carcinoma: a meta-analysis.
    Liu J; Xie B; Chen S; Jiang F; Meng W
    BMC Med Genet; 2014 Aug; 15():92. PubMed ID: 25108400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between two common polymorphisms in MicroRNAs and hepatocellular carcinoma risk in Asian population.
    Hu M; Zhao L; Hu S; Yang J
    PLoS One; 2013; 8(2):e57012. PubMed ID: 23437296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCND1 rs9344 polymorphism is associated with the risk of hepatocellular carcinoma in Caucasian population.
    Wang DD; Duan WD; Zhu ZM; Tu YL; Dou CQ; Han MM; Zhang B; Zhao W; Jiang K
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S516-S518. PubMed ID: 29970717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
    Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
    J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of the association between microRNA-499 rs3746444 A/G polymorphism and cancer risk.
    Sun H; Li Q; Yang T; Wang W
    Tumour Biol; 2014 Mar; 35(3):2351-8. PubMed ID: 24258110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rs3746444 polymorphism and susceptibility to hepatocellular carcinoma: evidence from published studies.
    Liu F; Lin H; Cheng Y; Yang L; Liu Y
    Cell Biochem Biophys; 2014 Dec; 70(3):1957-61. PubMed ID: 25074528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
    Li JF; Zheng EQ; Xie M
    Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of Hsa-mir-499 polymorphism (rs3746444) for cancer risk: evidence from 31 case-control studies.
    Chen C; Yang S; Chaugai S; Wang Y; Wang DW
    BMC Med Genet; 2014 Nov; 15():126. PubMed ID: 25433484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the association between five polymorphisms and risk of hepatocellular carcinoma: A meta-analysis.
    Yu JY; Hu F; Du W; Ma XL; Yuan K
    J Chin Med Assoc; 2017 Apr; 80(4):191-203. PubMed ID: 28188097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of ALDH2 and ADH2 are not associated with risk of hepatocellular carcinoma among East Asians.
    Zhou D; Xiao L; Zhang Y; Xian J; Jiang J; Zong W; Huang Z; Yang Y
    Tumour Biol; 2012 Jun; 33(3):841-6. PubMed ID: 22231434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the CYP1A1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Yu BW; Zhang LQ; Teng XL; Zhang Y; Zou LB; Ying HY
    Genet Mol Res; 2015 Feb; 14(1):1076-84. PubMed ID: 25730047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the epidermal growth factor 61*A/G polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Sun S; Jin GJ; Zhao Y; Kang H
    Asian Pac J Cancer Prev; 2015; 16(7):3009-14. PubMed ID: 25854398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant association between MTHFR C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Sun H; Han B; Zhai H; Cheng X; Ma K
    Tumour Biol; 2014 Jan; 35(1):189-93. PubMed ID: 24132589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive evaluation of single nucleotide polymorphisms associated with hepatocellular carcinoma risk in Asian populations: A systematic review and network meta-analysis.
    Zhang C; Ye Z; Zhang Z; Zheng J; Tang Y; Hou E; Huang Z; Meng L
    Gene; 2020 Apr; 735():144365. PubMed ID: 31935498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis.
    Wei YG; Liu F; Li B; Chen X; Ma Y; Yan LN; Wen TF; Xu MQ; Wang WT; Yang JY
    World J Gastroenterol; 2011 Sep; 17(34):3941-7. PubMed ID: 22025883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An A/G polymorphism rs3746444 in miR-499 is associated with increased cancer risk: a meta-analysis.
    Wang N; Tian ZQ; Li Y; Zhou RM; Wang GY
    Genet Mol Res; 2013 Sep; 12(3):3955-64. PubMed ID: 24085457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.